Halaman 3 - Kanker testis Dokter Terbaik - TOP-102 dokter

Dr. Dror Levin berspesialisasi dalam onkologi pediatrik, dengan fokus pada kanker tulang (sarkoma) pada anak-anak di Sourasky Medical Center.

• Direktur departemen hematologi onkologi anak di Sourasky Medical Center
• Spesialisasi dalam hematologi dan onkologi pediatrik di Schneider Children's Medical Center
• Anggota Masyarakat Hematologi dan Onkologi Pediatrik Israel (ISPHO)
• Terlatih dalam onkologi tulang dan jaringan lunak di Rizzoli Orthopaedic Institute di Italia

Dr. Turkan Ozturk Topcu berspesialisasi dalam berbagai jenis kanker, termasuk kanker testis, dengan pelatihan di pusat-pusat internasional terkemuka seperti MD Anderson dan Sunnybrook Odette.

• Spesialis Onkologi Medis sejak 2015 dari Universitas Teknik Karadeniz
• Menjalani pelatihan di MD Anderson Cancer Center di AS
• Memperoleh keahlian lebih lanjut di Sunnybrook Odette Cancer Center di Kanada
• Bekerja dengan protokol pengobatan lanjutan untuk kanker testis

Prof. Haim Matskin adalah otoritas terkemuka dalam onko-urologi, yang berspesialisasi dalam pengobatan kanker testis di Sourasky Medical Center.

• Memimpin Departemen Urologi di Sourasky Medical Center
• Menjadi ahli dalam brakiterapi dan krioterapi untuk tumor ganas
• Menjadi anggota Asosiasi Medis Israel dan asosiasi urologi internasional

Prof. Jack Baniel memimpin departemen urologi di Rabin Medical Center, berspesialisasi dalam bedah kanker dengan teknik nerve-sparing menggunakan presisi robotik. Beliau mendirikan departemen onkourologi di Rumah Sakit Beilinson.

• Melakukan rekonstruksi kandung kemih dan prostatektomi robotik
• Menerbitkan lebih dari 100 artikel ilmiah tentang uro-onkologi
• Menjadi anggota asosiasi urologi Eropa dan Amerika
• Terlibat dalam kolaborasi penelitian klinis global

Dr. Avi Beri berspesialisasi dalam perawatan urologi komprehensif di Sourasky Medical Center, termasuk prostatektomi dan TURP.

• Ahli dalam pengobatan batu ginjal dan vasektomi
• Memberikan konsultasi urologi untuk berbagai kondisi
• Berfokus pada membantu pasien mencapai hidup yang sehat

Associate Professor Tahsin Ozatli berspesialisasi dalam kanker payudara, paru-paru, dan gastrointestinal di Istinye Liv University Hospital.

• Spesialis Penyakit Dalam dengan pengalaman di berbagai klinik onkologi di Turki
• Dipromosikan menjadi Associate Professor pada tahun 2016
• Menempuh pendidikan di Fakultas Kedokteran Universitas Selcuk

Associate Professor Dr. Yusuf Acikgoz membawa keahlian onkologi internasional dari Ohio State University ke Rumah Sakit Universitas Lokman Hekim Ankara.

• Spesialisasi dalam onkologi medis dengan fokus pada kanker testis
• Berpartisipasi dalam uji klinis Fase III seperti CheckMate-649 dan Fortitude-101
• Tersertifikasi dalam Praktik Klinis yang Baik dan Perlindungan Subjek Manusia
• Anggota dari American Society of Clinical Oncology (ASCO)

Profesor Cemil Bilir membawa lebih dari 15 tahun pengalaman khusus dalam onkologi medis, dengan pelatihan di institusi terkemuka seperti Cleveland Clinic dan Northeastern University.

• Spesialisasi dalam mengobati kanker testis menggunakan protokol terbaru
• Menjadi anggota ASCO dan ESMO – tetap mengikuti standar global
• Mengajar calon ahli onkologi sebagai profesor di Universitas Sakarya
• Menyelesaikan fellowship di Pusat Bioteknologi Farmasi Universitas Northeastern

Associate Professor Nail Paksoy berspesialisasi dalam pengobatan kanker testis, dengan fellowship onkologi medis dari Universitas Istanbul dan Sertifikasi Dewan ESMO.

• Berpartisipasi dalam 8 uji klinis internasional untuk pengobatan kanker
• Menerbitkan berbagai studi tentang kanker metastasis di jurnal peer-reviewed
• Menjadi anggota European Society for Medical Oncology (ESMO)

30+ tahun spesialisasi dalam viroterapi – Dr. Jaunalksne memimpin Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins.

• Lulusan Institut Medis Riga dengan magang di Penyakit Dalam
• Kepala Pusat Imunologi Klinis – mengawasi perawatan imunologi mutakhir
• Berfokus pada pendekatan viroterapi inovatif untuk pengobatan kanker

Spesialis dalam onkologi medis, Dr. Alemdar membawa keahlian terfokus pada kanker testis di Kompleks Rumah Sakit Medical Park Antalya.

• Menempuh pendidikan di Universitas Akdeniz, salah satu sekolah kedokteran terkemuka di Turki
• Pengalaman dedikasi selama lebih dari 7 tahun di bidang onkologi medis
• Menangani diagnosis serta perencanaan perawatan untuk kanker testis
• Bekerja di rumah sakit terakreditasi JCI dengan fasilitas onkologi mutakhir

Dr. Ozden memiliki lebih dari 20 tahun pengalaman dalam penyakit dalam dan onkologi medis, dengan spesialisasi kanker testis di Rumah Sakit VM Medical Park Pendik.

• Menyelesaikan subspesialisasi onkologi medis di Fakultas Kedokteran Universitas Kocaeli
• Bekerja di Rumah Sakit Swasta Safa Bağcılar dan Rumah Sakit Batı Bahat Küçükçekmece
• Lulus dari Universitas Istanbul, Fakultas Kedokteran Cerrahpaşa

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Kepala Departemen Urologi di Rambam Medical Center, Dr. Amiel spesialisasi dalam onkologi urologi.

• Pengalaman luas dalam mengobati kanker testis
• Memimpin salah satu departemen urologi terbaik di Israel
• Berfokus pada prosedur bedah onkologi

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.